BackCVS Health Overview
CVS Health Corp

CVS Health Target Price

Where could CVS trade next? Consensus target price: $110.

Get informed when a big investor buys or sells

+ Follow

Share Price

$94.66

Average Target Price

$112.4118.8% upside

22 analysts in the last 4 months

High: $126 | Low: $103

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-09-09Bernstein$11218.3% upsideOpen
2026-09-09BMO Capital$11218.3% upsideOpen
2026-09-09Piper Sandler$11218.3% upsideOpen
2026-09-03UBS$11824.7% upsideOpen
2026-08-19Argus Research$11420.4% upsideOpen
2026-08-06Robert W. BairdMichael Ha$10713% upsideOpen
2026-08-06UBSKevin Caliendo$12633.1% upsideOpen
2026-08-06Barclays$10814.1% upsideOpen
2026-07-24UBS$12228.9% upsideOpen
2026-07-14Truist FinancialDavid MacDonald$11824.7% upsideOpen
2026-07-13Wells Fargo$12329.9% upsideOpen
2026-07-09RBC Capital$11319.4% upsideOpen
2026-07-07Cantor Fitzgerald$11016.2% upsideOpen
2026-07-06HSBC$1038.8% upsideOpen
2026-06-08Mizuho Securities$11521.5% upsideOpen
2026-06-04Morgan Stanley$11117.3% upsideOpen
2026-06-01Truist Financial$10814.1% upsideOpen
2026-06-01Piper SandlerJessica Tassan$11319.4% upsideOpen
2026-05-26BarclaysAndrew Mok$10612% upsideOpen
2026-05-20Mizuho Securities$11016.2% upsideOpen
2026-05-14Morgan Stanley$10612% upsideOpen
2026-05-13Bernstein$10612% upsideOpen
2026-05-07RBC Capital$10713% upsideOpen
2026-05-07Deutsche Bank$922.8% downsideOpen
2026-05-07Truist Financial$1027.8% upsideOpen
2026-05-07BarclaysAndrew Mok$1016.7% upsideOpen
2026-04-15Robert W. Baird$940.7% downsideOpen
2026-03-05Leerink PartnersMichael Cherny$983.5% upsideOpen
2026-01-28Argus Research$904.9% downsideOpen
2026-01-06Bernstein$913.9% downsideOpen
2025-12-12Bernstein$878.1% downsideOpen
2025-12-10Mizuho SecuritiesAnn Hynes$950.4% upsideOpen
2025-12-10Robert W. Baird$922.8% downsideOpen
2025-12-10Piper SandlerJessica Tassan$1016.7% upsideOpen
2025-12-10Morgan Stanley$931.8% downsideOpen
2025-12-10Barclays$931.8% downsideOpen
2025-12-10UBSKevin Caliendo$972.5% upsideOpen
2025-12-10Truist Financial$1005.6% upsideOpen
2025-12-04Bernstein$869.1% downsideOpen
2025-10-30RBC Capital$931.8% downsideOpen
2025-10-24UBS$961.4% upsideOpen
2025-10-14Truist FinancialDavid MacDonald$922.8% downsideOpen
2025-10-14Morgan StanleyErin Wright$896% downsideOpen
2025-10-14Goldman Sachs$913.9% downsideOpen
2025-10-09Mizuho SecuritiesAnn Hynes$887% downsideOpen
2025-10-07Wells Fargo$1038.8% upsideOpen
2025-09-04BarclaysAndrew Mok$878.1% downsideOpen
2025-08-18UBSKevin Caliendo$7916.5% downsideOpen
2025-08-14Robert W. BairdMichael Ha$8213.4% downsideOpen
2025-06-02BarclaysAndrew Mok$7916.5% downsideOpen

CVS Health (CVS) FAQ

CVS Health posts a target price of $110. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

A target price of $110 for CVS means covering analysts, on average, see the stock 18.8% upside of $94.66 over about 12 months. Dig into who set the high and low targets and how recently they updated — freshness matters as much as the average itself.

Context for CVS's target price usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; CVS Health's other metric pages and overview cover the third.

Judging CVS Health against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in target price easier to interpret. Start with $110 here, then scan peer and history charts to see if the gap is persistent.